Polymers for artificial joints

Polymeric Biomaterials: Structure and Function

Volumn 1, Issue , 2013, Pages 851-883

  Kyomoto, Masayuki ^a,b,c   Moro, Toru ^b   Ishihara, Kazuhiko ^a,b  

^a School of Engineering   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOCERA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992142005     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13757     Document Type: Chapter

References (113)

1. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. 2005. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 87(7):1487-1497.
2. Malchau H, Herberts P, Eisler T, Garellick G, Söderman P. 2002. The swedish total hip replacement register. J Bone Joint Surg Am 84 (Suppl 2):2-20.
3. Sierra RJ, Cooney WP 4th, Pagnano MW, Trousdale RT, and Rand, JA. 2004. Reoperations after 3200 revision TKAs: Rates, etiology, and lessons learned. Clin Orthop Relat Res 425:200-206.
4. Rand JA, Trousdale RT, Ilstrup DM, Harmsen WS. 2003. Factors affecting the durability of primary total knee prostheses. J Bone Joint Surg Am 85(2):259-265.
5. Orthopedic medical device market in Japan 2007. In: Medical Bionics (Artificial Organ) Market 2007. Tokyo, Japan: Yano Research Institute, Ltd., pp. 275-344.
6. Harris WH. 1995. The problem is osteolysis. Clin Orthop Relat Res 311:46-53.
7. Sochart DH. 1999. Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty. Clin Orthop Relat Res 363:135-150.
8. ASTM F648-07, 2007. Standard specification for ultra-high-molecular-weight polyethylene powder and fabricated form for surgical implants. West Conshohocken, PA: ASTM International.
9. ISO 5834-1, 2007. Implants for surgery—Ultra-high-molecular-weight polyethylene—Part 1: Powder form., Geneva, Switzerland: International Organization for Standardization.
10. Charnley J. 1961. Arthroplasty of the hip. A new operation. Lancet 27;1(7187):1129-1132.
11. Dupont JA, Charnley J. 1972. Low-friction arthroplasty of the hip for the failures of previous operations. J Bone Joint Surg Br 54(1):77-87.
12. Isaac GH, Dowson D, Wroblewski BM. 1996. An investigation into the origins of time-dependent variation in penetration rates with Charnley acetabular cups—Wear, creep or degradation? Proc Inst Mech Eng H 210(3):209-216.
13. Kurtz SM, Muratoglu OK, Evans M, Edidin AA. 1999. Advances in the processing, sterilization, and crosslinking of ultra-high molecular weight polyethylene for total joint arthroplasty. Biomaterials 20(18):1659-1688.
14. Wright TM, Bartel DL. 1986. The problem of surface damage in polyethylene total knee components. Clin Orthop Relat Res 205:67-74.
15. Connelly GM, Rimnac CM, Wright TM, Hertzberg RW, Manson JA. 1984. Fatigue crack propagation behavior of ultrahigh molecular weight polyethylene. J Orthop Res 2(2):119-125.
16. Oonishi H, Takayama Y, Tsuji E. 1992. Improvement of polyethylene by irradiation in artificial joints. Radiat Phys Chem 39(6):495-504.
17. Kyomoto M, Ueno M, Kim SC, Oonishi H, Oonishi H. 2007. Wear of ‘100 Mrad’ cross-linked polyethylene: Effects of packaging after 30 years real-time shelf-aging. J Biomater Sci Polym Ed 18(1):59-70.
18. Grobbelaar CJ, Du Plessis TA, Marais F. 1978. The radiation improvement of polyethylene prostheses: A preliminary study. J Bone Joint Surg Br 60:370-374.
19. Oonishi H, Wakitani S, Murata N, Saito M, Imoto K, Kim S, Matsuura M. 2000. Clinical experience with ceramics in total hip replacement. Clin Orthop Relat Res 379:77-84.
20. Wroblewski BM, Siney PD, Dowson D, Collins SN. 1996. Prospective clinical and joint simulator studies of a new total hip arthroplasty using alumina ceramic heads and cross-linked polyethylene cups. J Bone Joint Surg Br 78(2):280-285.
21. Li S, Burstein AH. 1994. Ultra-high molecular weight polyethylene. The material and its use in total joint implants. J Bone Joint Surg Am 76(7):1080-1090.
22. Muratoglu OK, Bragdon CR, O’Connor DO, Jasty M, Harris WH. 2001. A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. J Arthroplasty 16(2):149-160.
23. Oonishi H, Kim SC, Takao Y, Kyomoto M, Iwamoto M, Ueno M. 2006. Wear of highly cross-linked polyethylene acetabular cup in Japan. J Arthroplasty 21(7):944-949.
24. McKellop H, Shen FW, Lu B, Campbell P, Salovey R. 2000. Effect of sterilization method and other modifications on the wear resistance of acetabular cups made of ultra-high molecular weight polyethylene. A hip-simulator study. J Bone Joint Surg Am 82(12):1708-1725.
25. Dowd JE, Sychterz CJ, Young AM, Engh CA. 2000. Characterization of long-term femoral-head-penetration rates. Association with and prediction of osteolysis. J Bone Joint Surg Am 82(8):1102-1107.
26. Oparaugo PC, Clarke IC, Malchau H, Herberts P. 2001. Correlation of wear debris-induced osteolysis and revision with volumetric wear-rates of polyethylene: A survey of 8 reports in the literature. Acta Orthop Scand 72(1):22-28.
27. Röhrl S, Nivbrant B, Mingguo L, Hewitt B. 2005. In vivo wear and migration of highly cross-linked polyethylene cups a radiostereometry analysis study. J Arthroplasty 20(4):409-413.
28. Martell JM, Verner JJ, Incavo SJ. 2003. Clinical performance of a highly cross-linked polyethylene at two years in total hip arthroplasty: A randomized prospective trial. J Arthroplasty 18(7 Suppl 1):55-59.
29. Krushell RJ, Fingeroth RJ, Cushing MC. 2005. Early femoral head penetration of a highly cross-linked polyethylene liner vs a conventional polyethylene liner. A case controlled study. J Arthroplasty 20(7 Suppl 3):73-76.
30. D’Antonio JA, Manley MT, Capello WN, Bierbaum BE, Ramakrishnan R, Naughton M, Sutton K. 2005. Five-year experience with Crossfire highly cross-linked polyethylene. Clin Orthop Relat Res 441:143-150.
31. Heisel C, Silva M, dela Rosa MA, Schmalzried TP. 2004. Short-term in vivo wear of cross-linked polyethylene. J Bone Joint Surg Am 86:748-751.
32. Sychterz CJ, Engh CA Jr, Engh CA. 2004. A prospective, randomized clinical study comparing Marathon and Enduron polyethylene acetabular liners: 3 year results. J Arthroplasty 19:258.
33. Engh CA Jr, Stepniewski AS, Ginn SD, Beykirch SE, Sychterz-Terefenko CJ, Hopper RH Jr, Engh CA. 2006. A randomized prospective evaluation of outcomes after total hip arthroplasty using cross-linked Marathon and non-cross-linked Enduron polyethylene liners. J Arthroplasty 21(6 Suppl 2):17-25.
34. Digas G, Karrholm J, Thanner J, Malchau H, Herberts P. 2003. Highly cross-linked polyethylene in cemented THA: Randomized study of 61 hips. Clin Orthop Relat Res 417:126-138.
35. Manning DW, Chiang PP, Martell JM, Galante JO, Harris WH. 2005. In vivo comparative wear study of traditional and highly cross-linked polyethylene in total hip arthroplasty. J Arthroplasty 20:880-886.
36. Hopper RH Jr, Young AM, Orishimo KF, McAuley JP. 2003. Correlation between early and late wear rates in total hip arthroplasty with application to the performance of Marathon cross-linked polyethylene liners. J Arthroplasty 18(7 Suppl 1):60-67.
37. Digas G, Karrholm J, Thanner J, Malchau H, Herberts P. 2004. Highly cross-linked polyethylene in total hip arthroplasty: Randomized evaluation of penetration rate in cemented and uncemented sockets using radiostereometric analysis. Clin Orthop Relat Res 429:6-16.
38. Bragdon CR, Barrett S, Martell JM, Greene ME, Malchau H, Harris WH. 2006. Steady-state penetration rates of electron beam-irradiated, highly cross-linked polyethylene at an average 45-month follow-up. J Arthroplasty 21:935-943.
39. Dorr LD, Wan Z, Shahrdar C, Sirianni L, Boutary M, Yun A. 2005. Clinical performance of a Durasul highly cross-linked polyethylene acetabular liner for total hip arthroplasty at five years. J Bone Joint Surg Am 87:1816-1821.
40. Ries MD, Scott ML, Jani S. 2001. Relationship between gravimetric wear and particle generation in hip simulators: Conventional compared with cross-linked polyethylene. J Bone Joint Surg Am 83 (Suppl 2):116-122.
41. Bradford L, Kurland R, Sankaran M, Kim H, Pruitt LA, Ries MD. 2004. Early failure due to osteolysis associated with contemporary highly cross-linked ultra-high molecular weight polyethylene. A case report. J Bone Joint Surg Am 86(5):1051-1056.
42. Moro T, Takatori Y, Ishihara K, Kyomoto M, Nakamura K, Kawaguchi H. 2009. Progress of research in osteoarthritis. Invention of longer lasting artificial joints. Clin Calcium 19(11):1629-1637.
43. Shibata N, Tomita N. 2005. The anti-oxidative properties of α-tocopherol in γ-irradiated UHMWPE with respect to fatigue and oxidation resistance. Biomaterials 26(29):5755-5762.
44. Suzuki M, Lee T, Miyagi J, Kobayashi T, Sasho T, Nakagawa K, Fujiwara K, Nishimura N, Kuramoto K, Moriya H, Takahashi K. 2010. Evaluation of vitamin E added ultra high molecular weight polyethylene in total knee arthroplasty. Joint fluid concentrations of tocopherol and matrix metalloproteinase 9. J Bone Joint Surg Br 92-B (Suppl I): 131.
45. Brach Del Prever EM, Bistolfi A, Bracco P, Costa L. 2009. UHMWPE for arthroplasty: Past or future? J Orthop Traumatol 10(1):1-8.
46. Yoshida H, Morita Y, Ikeuchi K. 2003. Biological lubrication of hydrated surface layer in small intestine. In: Dowson D, editor. Tribological Research and Design for Engineering Systems. Amsterdam, the Netherlands: Elsevier, pp. 425-428.
47. Buckwalter JA, Rosenberg L. 1983. Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res 3(6):489-504.
48. Obara T, Mabuchi K, Iso T, Yamaguchi T. 1997. Increased friction of animal joints by experimental degeneration and recovery by addition of hyaluronic acid. Clin Biomech (Bristol, Avon) 12(4):246-252.
49. Ishikawa Y, Hiratsuka K, Sasada T. 2006. Role of water in the lubrication of hydrogel. Wear 261:500-504.
50. Longfield MD, Dowson D, Walker PS, Wright V. 1969. “Boosted lubrication” of human joints by fluid enrichment and entrapment. Biomed Eng 4(11):517-522.
51. Ikeuchi K, Kusaka J, Yamane D, Fujita S. 1999. Time-dependent wear process between lubricated soft materials. Wear 229:656-659.
52. Milner ST. 1991. Polymer brushes. Science 251:905-914.
53. Nagasaki Y, Kataoka K. 1996. An intelligent polymer brush. Trends Polym Sci 4(2):59-64.
54. Edmondson S, Osborne VL, Huck WTS. 2004. Polymer brushes via surface-initiated polymerizations. Chem Soc Rev 33:14-22.
55. Dyer DJ. 2006. Photoinitiated synthesis of grafted polymers. In: Abe A et al., editors. Advances in Polymer Science. Berlin, Germany: Springer-Verlag, pp. 47-65.
56. Moro T, Takatori Y, Ishihara K, Konno T, Takigawa Y, Matsushita T, Chung UI, Nakamura K, Kawaguchi H. 2004. Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nat Mater 3:829-837.
57. Moro T, Takatori Y, Ishihara K, Nakamura K, Kawaguchi H. 2006. 2006 Frank Stinchfield Award: Grafting of biocompatible polymer for longevity of artificial hip joints. Clin Orthop Relat Res 453:58-63.
58. Moro T, Kawaguchi H, Ishihara K, Kyomoto M, Karita T, Ito H, Nakamura K, Takatori Y. 2009. Wear resistance of artificial hip joints with poly(2-methacryloyloxyethyl phosphorylcholine) grafted polyethylene: Comparisons with the effect of polyethylene cross-linking and ceramic femoral heads. Biomaterials 30(16):2995-3001.
59. Ishihara K, Ueda T, Nakabayashi N. 1990. Preparation of phospholipid polymers and their properties as polymer hydrogel membranes. Polym J 22(5):355-360.
60. Brash JL. 2000. Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials. J Biomater Sci Polym Ed 11(11):1135-1146.
61. Zwaal RF, Comfurius P, van Deenen LL. 1977. Membrane asymmetry and blood coagulation. Nature 268(5618):358-360.
62. Hayward JA, Chapman D. 1984. Biomembrane surfaces as models for polymer design: The potential for haemocompatibility. Biomaterials 5(3):135-142.
63. Yamazaki K, Saito S, Tomioka H, Miyagishima M, Kobayashi K, Miyake T, Ishii H, Kawai A, Aomi S, Tagusari O, Niwaya K, Nakatani T, Kobayashi J, Kitamura S, Kihara S, Kurosawa H. 2006. Clinical trial of EVAHEART: Next generation left ventricular assist device. Circulation J 70 (Suppl 1):59.
64. Myers GJ, Gardiner K, Ditmore SN, Swyer WJ, Squires C, Johnstone DR, Power CV, Mitchell LB, Ditmore JE, Cook B. 2005. Clinical evaluation of the Sorin Synthesis oxygenator with integrated arterial filter. J Extra Corpor Technol 37(2):201-206.
65. Myers GJ, Johnstone DR, Swyer WJ, McTeer S, Maxwell SL, Squires C, Ditmore SN et al. 2003. Evaluation of Mimesys phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults. J Extra Corpor Technol 35(1):6-12.
66. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators. 2006. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 114(8):798-806.
67. Gershlick A, Kandzari DE, Leon MB, Wijns W, Meredith IT, Fajadet J, Popma JJ, Fitzgerald PJ, Kuntz RE; ENDEAVOR Investigators. 2007. Zotarolimus-eluting stents in patients with native coronary artery disease: Clinical and angiographic outcomes in 1,317 patients. Am J Cardiol 100(8B):45M-55M.
68. Kandzari DE, Leon MB. 2006. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent. J Interv Cardiol 19(5):405-413.
69. Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ; ENDEAVOR II Trial Investigators. 2007. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol 100(5):818-823.
70. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O’Shaughnessy C, Ball MW, Turco M et al. 2006. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: A randomized controlled trial. J Am Coll Cardiol 48(12):2440-2447.
71. Abizaid A, Popma JJ, Tanajura LF, Hattori K, Solberg B, Larracas C, Feres F, Costa Jde R Jr, Schwartz LB. 2007. Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: The TriMaxx trial. Catheter Cardiovasc Interv 70(7):914-919.
72. Abizaid A, Lansky AJ, Fitzgerald PJ, Tanajura LF, Feres F, Staico R, Mattos L et al. 2007. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent. Am J Cardiol 99(10):1403-1408.
73. Han SH, Ahn TH, Kang WC, Oh KJ, Chung WJ, Shin MS, Koh KK, Choi IS, Shin EK. 2006. The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: Randomized controlled prospective study. Am Heart J 152(5):887, e1-e7.
74. Kwok OH, Chow WH, Law TC, Chiu A, Ng W, Lam WF, Hong MK, Popma JJ. 2005. First human experience with angiopeptin-eluting stent: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheter Cardiovasc Interv 66(4):541-546.
75. Airoldi F, Di Mario C, Ribichini F, Presbitero P, Sganzerla P, Ferrero V, Vassanelli C et al. 2005. 17-Betaestradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. Am J Cardiol 96(5):664-667.
76. Rodriguez A, Rodríguez Alemparte M, Fernández Pereira C, Sampaolesi A, da Rocha Loures Bueno R, Vigo F, Obregón A, Palacios IF; LASMAL investigators. 2005. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results. Am J Med 118(7):743-751.
77. Bakhai A, Booth J, Delahunty N, Nugara F, Clayton T, McNeill J, Davies SW, Cumberland DC, Stables RH; SV Stent Investigators. 2005. The SV stent study: A prospective, multicentre, angiographic evaluation of the BiodivYsio phosphorylcholine coated small vessel stent in small coronary vessels. Int J Cardiol 102(1):95-102.
78. Shinozaki N, Yokoi H, Iwabuchi M, Nosaka H, Kadota K, Mitsudo K, Nobuyoshi M. 2005. Initial and follow-up results of the BiodivYsio phosphorylcholine coated stent for treatment of coronary artery disease. Circ J 69(3):295-300.
79. Hausleiter J, Kastrati A, Mehilli J, Schühlen H, Pache J, Dotzer F, Glatthor C, Siebert S, Dirschinger J, Schömig A; ISAR-SMART-2 Investigators. 2004. A randomized trial comparing phosphorylcholinecoated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. J Intern Med 256(5):388-397.
80. Boland JL, Corbeij HA, Van Der Giessen W, Seabra-Gomes R, Suryapranata H, Wijns W, Hanet C et al. 2000. Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent 3(4):215-225.
81. Kuiper KK, Nordrehaug JE. 2000. Early mobilization after protamine reversal of heparin following implantation of phosphorylcholine-coated stents in totally occluded coronary arteries. Am J Cardiol 85(6):698-702.
82. Grenadier E, Roguin A, Hertz I, Peled B, Boulos M, Nikolsky E, Amikam S, Kerner A, Cohen S, Beyar R. 2002. Stenting very small coronary narrowings (<2 mm) using the biocompatible phosphorylcholinecoated coronary stent. Catheter Cardiovasc Interv 55(3):303-308.
83. Kyomoto M, Moro T, Konno T, Takadama H, Yamawaki N, Kawaguchi H, Takatori Y, Nakamura K, Ishihara K. 2007. Enhanced wear resistance of modified cross-linked polyethylene by grafting with poly(2-methacryloyloxyethyl phosphorylcholine). J Biomed Mater Res A 82(1):10-17.
84. Kyomoto M, Moro T, Miyaji F, Hashimoto M, Kawaguchi H, Takatori Y, Nakamura K, Ishihara K. 2008. Effect of 2-methacryloyloxyethyl phosphorylcholine concentration on photo-induced graft polymerization of polyethylene in reducing the wear of orthopaedic bearing surface. J Biomed Mater Res A 86(2):439-447.
85. Kyomoto M, Moro T, Miyaji F, Hashimoto M, Kawaguchi H, Takatori Y, Nakamura K, Ishihara K. 2009. Effects of mobility/immobility of surface modification by 2-methacryloyloxyethyl phosphorylcholine polymer on the durability of polyethylene for artificial joints. J Biomed Mater Res A 90(2):362-371.
86. Brown SA, Hastings RS, Mason JJ, Moet A. 1990. Characterization of short-fibre reinforced thermoplastics for fracture fixation devices. Biomaterials 11(8):541-547.
87. Kurtz SM, Devine JN. 2007. PEEK biomaterials in trauma, orthopedic, and spinal implants. Biomaterials 28(32):4845-4869.
88. Wang A, Lin R, Stark C, Dumbleton JH. 1999. Suitability and limitations of carbon fiber reinforced PEEK composites as bearing surfaces for total joint replacements. Wear 225-229:724-727.
89. Joyce TJ, Rieker C, Unsworth A. 2006. Comparative in vitro wear testing of PEEK and UHMWPE capped metacarpophalangeal prostheses. Biomed Mater Eng 16(1):1-10.
90. Latif AM, Mehats A, Elcocks M, Rushton N, Field RE, Jones E. 2008. Pre-clinical studies to validate the MITCH PCR Cup: A flexible and anatomically shaped acetabular component with novel bearing characteristics. J Mater Sci: Mater Med 19(4):1729-1736.
91. Yu S, Hariram KP, Kumar R, Cheang P, Aik KK. 2005. In vitro apatite formation and its growth kinetics on hydroxyapatite/polyetheretherketone biocomposites. Biomaterials 26(15):2343-2352.
92. Fan JP, Tsui CP, Tang CY, Chow CL. 2004. Influence of interphase layer on the overall elasto-plastic behaviors of HA/PEEK biocomposite. Biomaterials 25(23):5363-5373.
93. Kyomoto M, Ishihara K. 2009. Self-initiated surface graft polymerization of 2-methacryloyloxyethyl phosphorylcholine on poly(ether-ether-ketone) by photo-irradiation. ACS Appl Mater Interfaces 1(3):537-542.
94. Kyomoto M, Moro T, Takatori Y, Kawaguchi H, Nakamura K, Ishihara K. 2010. Self-initiated surface grafting with poly(2-methacryloyloxyethyl phosphorylcholine) on poly(ether-ether-ketone). Biomaterials 31(6):1017-1024.
95. Giancaterina S, Rossi A, Rivaton A, Gardette JL. 2000. Photochemical evolution of poly(ether ether ketone). Polym Degrad Stab 68(1):133-144.
96. Wang H, Brown HR, Li Z. 2007. Aliphatic ketones/water/alcohol as a new photoinitiating system for the photografting of methacrylic acid onto high-density polyethylene. Polymer 48(4):939-948.
97. Yang W, Rånby B. 1999. Photoinitiation performance of some ketones in the LDPE-acrylic acid surface photografting system. Eur Polym J 35(8):1557-1568.
98. Qiu C, Nguyen QT, Ping Z. 2007. Surface modification of cardo polyetherketone ultrafiltration membrane by photo-grafted copolymers to obtain nanofiltration membranes. J Membr Sci 295(1-2):88-94.
99. Nguyen HX, Ishida H. 1986. Molecular analysis of the melting behaviour of poly(aryl-ether-etherketone). Polymer 27(9):1400-1405.
100. Cole KC, Casella IG. 1992. Fourier transform infrared spectroscopic study of thermal degradation in films of poly(etheretherketone). Thermochim Acta 211:209-228.
101. Qiu KY, Si K. 1996. Grafting reaction of macromolecules with pendant amino groups via photoinitiation with benzophenone. Macromol Chem Phys 197:2403-2413.
102. Kuehn KD, Ege W, Gopp U. 2005. Acrylic bone cements: Composition and properties. Orthop Clin North Am 36(1):17-28.
103. Charnley J. 1964. The bonding of prostheses to bone by cement. J Bone Joint Surg Br 46:518-529.
104. Buchholz HW, Elson RA, Engelbrecht E, Lodenkämper H, Röttger J, Siegel A. 1981. Management of deep infection of total hip replacement. J Bone Joint Surg Br 63(3):342-353.
105. Wahlig H, Dingeldein E. 1980. Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 51(1):49-56.
106. Hope PG, Kristinsson KG, Norman P, Elson RA. 1989. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 71(5):851-855.
107. Ishihara K, Arai J, Nakabayashi N, Morita S, Furuya K. 1992. Adhesive bone cement containing hydroxyapatite particle as bone compatible filler. J Biomed Mater Res 26(7):937-945.
108. Lee RR, Ogiso M, Watanabe A, Ishihara K. 1997. Examination of hydroxyapatite filled 4-META/MMATBB adhesive bone cement in vitro and in vivo environment. J Biomed Mater Res 38(1):11-16.
109. Morita S, Kawachi S, Yamamoto H, Shinomiya K, Nakabayashi N, Ishihara K. 1999. Total hip arthroplasty using bone cement containing tri-n-butylborane as the initiator. J Biomed Mater Res 48(5):759-763.
110. Sakai T, Morita S, Shinomiya K, Watanabe A, Nakabayashi N, Ishihara K. 2000. Prevention of fibrous layer formation between bone and adhesive bone cement: In vivo evaluation of bone impregnation with 4-META/MMA-TBB cement. J Biomed Mater Res 52(1):24-29.
111. Sakai T, Morita S, Shinomiya K, Watanabe A, Nakabayashi N, Ishihara K. 2000. In vivo evaluation of the bond strength of adhesive 4-META/MMA-TBB bone cement under weight-bearing conditions. J Biomed Mater Res 52(1):128-134.
112. Ohtsuki C, Miyazaki T, Kyomoto M, Tanihara M, Osaka A. 2001. Development of bioactive PMMA-based cement by modification with alkoxysilane and calcium salt. J Mater Sci: Mater Med 12(10-12):895-899.
113. Miyazaki T, Ohtsuki C, Kyomoto M, Tanihara M, Mori A, Kuramoto K. 2003. Bioactive PMMA bone cement prepared by modification with methacryloxypropyltrimethoxysilane and calcium chloride. J Biomed Mater Res A 67(4):1417-1423.